Angelini Ventures Invests in Digital Health Solution for Primary Care
Rome, Italy – March 12, 2025 – Angelini Ventures, the corporate venture arm of Angelini Industries, announced today a €10 million Series A financing round in Vantis Health, a Munich-based company. Vantis is leveraging digital therapies and innovative care models to transform primary care, particularly for patients with chronic conditions.
This investment highlights Angelini Ventures’ strategic focus on supporting companies that drive digital health innovation. Vantis is addressing a critical challenge in Germany: a growing shortage of general practitioners (GPs) in primary care, and a rise in chronic conditions. The situation mirrors broader trends across Europe, with a projected healthcare professional shortage of approximately four million by 2030.
Vantis’ approach combines technological improvements and practice management with digital therapy applications. The investment by Angelini Ventures, along with participation from Bayern Kapital, Twip Impact Ventures, and existing investors firstminute and b2venture, will enable Vantis to expand its team and enhance its use of telemedicine, continuous monitoring, digital therapies, and AI-powered processes.
Nils Bottler, whose Principal in Digital Health at Angelini Ventures, stated, “Vantis is redefining primary care by combining digital innovation with hands-on clinical expertise. Its approach not only streamlines practice operations but also enables physicians to deliver more personalized and data-driven care, particularly for patients with chronic conditions. This model has the potential to address similar healthcare challenges across Europe, aligning with our commitment to supporting companies that bring tangible, technology-enabled improvements to healthcare.”
Till Jansen, Co-founder and CEO of Vantis, emphasized the importance of digital transformation: “Significant investments are essential for the digital transformation of the healthcare system so that in the end, everyone benefits: doctors, patients, and payers. As a software company with our own practices, we have the unique ability to tailor our technology to the current challenges in primary care and continuously optimize it. Our goal is to achieve better treatment outcomes for patients while simplifying doctors’ daily routines—so they can focus more on what truly matters: providing medical care.”
About Angelini Ventures
Angelini Ventures is the venture capital arm of Angelini Industries, focused on investments in BioTech and Digital Health. The firm plans to invest €300 million globally, building on a portfolio that currently includes approximately €100 million across 18 companies.
About Vantis
Vantis, based in Munich, is a pioneer in digital healthcare, focused on addressing the challenges of the German healthcare system, especially the shortage of doctors and the rise of chronic conditions.
About Angelini Industries
Angelini Industries is a multinational industrial group founded in 1919, employing approximately 5,800 people across 21 countries with a wide range of products and services in the health, industrial technology, and consumer goods sectors.
